← All indications
Bone Marrow Cells
Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.
Subtype terms (6)
More specific conditions that are subtypes of Bone Marrow Cells in the MeSH hierarchy.
- Endothelial Progenitor Cells
4 drugs (2 approved, 2 experimental)
- Granulocytes
- Hematopoietic Stem Cells
9 drugs (8 approved, 1 experimental)
- Megakaryocytes
- Monocytes
1 drug approved
- Reticulocytes
Drugs by status
Phase 4 trials (3)
Phase 3 trials (1)
Phase 2 trials (44)
- cladribine
- decitabine
- azacitidine
- dexrazoxane
- plerixafor
- autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes
- venetoclax
- busulfan
- cb-839
- clofarabine
- quizartinib
- gemtuzumab ozogamicin
- tacrolimus
- naltrexone
- aldesleukin
- idarubicin
- nivolumab
- autologous natural killer cells
- inotuzumab ozogamicin
- bosutinib
- vincristine
- atorvastatin
- allogeneic hematopoietic stem cells
- sitagliptin
- ruxolitinib
- salsalate
- cyclosporine
- mycophenolate
- cyclophosphamide
- stem cells
- +14 more
Phase 1 trials (14)
Other trials (2)